Carriers of the A allele who adhered better to the pattern had higher TG values than non-carriers, independent of age, gender, energy intake, NAFLD diagnosis, adherence to “Prudent” dietary pattern, TM6SF2-rs58542926 and antilipidemic drug therapy. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.